Are you Dr. Papadopoulos?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 50 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Summary
- Dr. Nicholas Papadopoulos, MD is an oncologist in Houston, Texas. He is currently licensed to practice medicine in Texas. He is affiliated with University of Texas M.D. Anderson Cancer Center and is an Associate Professor of Medicine at University Tex Houston.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1976 - 1977
Baylor College of MedicineResidency, Internal Medicine, 1973 - 1975
University of AthensClass of 1966
Certifications & Licensure
TX State Medical License 1978 - 2025
Clinical Trials
- Biochemotherapy With Temozolomide for Metastatic Melanoma Start of enrollment: 2007 Mar 01
- Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients Start of enrollment: 2006 Feb 09
- Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma Start of enrollment: 2009 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsPhase I/II study of hepatic arterial infusion of nab-paclitaxel in patients with metastatic melanoma to the liverJesus Vera-Aguilera, Agop Y. Bedikian, Roland L. Bassett, Wen-Jen Hwu, Kevin B. Kim, Yong Qin, Suzanne Cain, Edwina Washington, Michael A. Davies, Sunil M. Patel, Jade...> ;American Journal of Clinical Oncology. 2018 Nov 1
- Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids.Nittoli, T.,Kelly, M. P.,Delfino, F.,Rudge, J.,Kunz, A.,Markotan, T.,Spink, J.,Chen, Z.,Shan, J.,Navarro, E.,Tait, M.,Provoncha, K.,Giurleo, J.,Zhao, F.,Jiang, X.,Hylt...> ;Bioorg. Med. Chem.. 2018 Apr 02
- 33 citationsRetrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2Isabella C. Glitza, Michelle Rohlfs, Nandita Guha-Thakurta, Roland L. Bassett, Chantale Bernatchez, Adi Diab, Scott E. Woodman, Cassian Yee, Rodabe N. Amaria, Sapna Pr...> ;ESMO Open. 2018 Jan 1
- Join now to see all
Press Mentions
Finding Care and Compassion at MD Anderson Through Multiple Cancer DiagnosesNovember 16th, 2022- Helps Clarify the Benefit of Chemotherapy in Stage II Cancers — ScienceDailyJune 4th, 2022
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
